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The ability of the two-chain form of tetanus toxin (TeTx), its constituent light (LC) or heavy (HC) chains, and papain 
fragment to block evoked acetylcholine (ACh) release in the buecal ganglia of Aplysia californica was studied electrophysi- 
ologically. Extracellularly applied, TeTx or its B fragment (consisting of LC and f12, the amino-terminal portion of HC) 
blocked ACh release, whereas LC, HC, or the f12 fragment did not affect it. Toxicity was restored when LC was bath 
applied together with HC or the ,82 fragment. When injected into the presynaptic neuron, TeTx, the B fragment or LC, 
but not HC, induced inhibition of ACh release. These results indicate that the blockade of ACh release by TeTx is mim- 
icked by intracellular ction of LC, the internalization ofwhich is mediated by the HC via its amino-terminal moiety. 
Tetanus toxin; Light chain; Heavy chain; Transmitter release; Central synapse; (Aplysia) 
1. INTRODUCTION 
Tetanus toxin (TeTx) is known to block the 
transmitter  elease from central nerve terminals 
and,  at much higher concentrat ion,  acetylchol ine 
(ACh)  release f rom motor  end-plates in vertebrates 
(for review see [1,2]). TeTx, produced in culture 
broth  o f  Clostridium tetani, is a two-chain protein 
consist ing of  heavy (HC, 98 kDa) and light (LC, 
52 kDa) chains l inked by a disulf ide bond [3]. Re- 
cent work on non-neuronal  preparat ions indicates 
that the toxic site for blocking of  the transmitter 
release exists on the LC of  TeTx. Catecholamine 
release was blocked in bovine adrenal  medul lary 
chromaf f in  cells permeabi l ized with streptolysin-O 
to al low internal izat ion of  LC [4], and intracel lular 
in ject ion of  the B fragment of  TeTx (consisting of  
/~2 the amino-terminal  moiety of  the HC which is 
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l inked to LC by a di-sulf ide bond) blocked 
capacitance changes associated with the 
catecholamine release [5]. These f indings contrast 
with the demonstrat ion [6-8],  in a neuro-neuronal  
chol inergic synapse of  Aplysia, of  the intracel lular 
requirement of  both LC and HC for the blocking 
act ion of  botu l inum neurotoxins (BoNTs). These 
toxins exhibit a gross structure similar to TeTx 
[1,2]. It seemed thus interesting to assess whether 
and how TeTx and its chains act on Aplysia 
synapses. These toxins can be injected into the 
presynaptic neurons and the release of  the 
neurotransmitter  is directly related to the 
postsynapt ic  response. 
2. EXPERIMENTAL 
2.1. Materials 
The two-chain form of tetanus toxin was prepared either by 
chymotrypsin cleavage of the single-chain form of the toxin 
(TeTx BC) or from culture filtrate (TeTx BE) according to a 
previous procedure [9]. Their constituent HC and LC were ob- 
tained by isoelectric focussing in a sucrose gradient with am- 
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Fig. 1. Effect of bath applied tetanus toxin (TeTx) on a cholinergic synapse of Aplysia. Postsynaptic responses evoked by the 
presynaptic action potential (once a minute) were recorded against ime. Typical experiments using three distinct preparations are 
reported. After a period of stabilization in synaptic responses (100%), the two-chain form TeTx BE or TeTx BC (10 -6 M) was bath 
applied at time 0. For comparison, the depression of synaptic transmission i duced by the botulinum toxin type A (BoNT A) at l0 -8 M 
is shown. 
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Fig.2. Intracellularly applied TeTx or TeTx LC depress the release of  ACh. The two-chain form TeTx (BC) or isolated LC was injected 
(arrow) into a presynaptic neuron. Concentrations of TeTx or LC in the micropipette used for the injection were (o) 2 x 10 -5 M, (*) 
2 x 10 -6 M and (o) 2 x I0 -v M leading to theoretical intracellular concentrations in the range of 2 × 10 -7 M, 2 × 10 -8 M and 2 x 
10 -9 M, respectively, assuming that the injected volume was about 1% of cell body. Note that the potency of LC to block ACh release 
is the same as that of TeTx. 
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pholyte under reducing conditions in 2 re•l/1 urea. Toxicity 
(LDso, s.c. in mice) was 2 ng/kg for TeTx BE or BC, 
100-300/~g/kg for both HC and LC. The B fragment of 
tetanus toxin obtained by papain cleavage [10,11] exhibited a
toxicity of 5-50/~g/kg. Following reduction of the latter frag- 
ment, the B2 fragment was isolated by is•electric focussing [10]. 
All toxin prepartions were dialysed into artificial sea water 
(ASW: 460 mM NaCl, 10 mM KC1, 11 mM CaC12, 25 mM 
MgCI2, 28 mM MgSO4, 10 mM Tris-HC1, pH 7.8), prior to use. 
Highly purified botulinum neurotoxin type A (BoNT A) was a 
gift from Dr J.O. Dolly, Dept of Neurochemistry, Imperial 
College, London (England). 
2.2. Electrophysiological recordings 
Experiments were made in Aplysia californica on identified 
cholincrgic neuro-neuronal synapses in the buccal ganglion [12] 
and on synapses in the cerebral ganglia [13] that release a not 
yet identified non-cholinergic transmitter [14]. Experimental 
procedures were similar to those used for the study of BoNT 
[6-8]. Briefly, dissected ganglia were pinned in a 1 ml chamber 
and superfused (10 ml/h) at room temperature (22-23°C) with 
ASW, except when toxin, chains or fragments were added to the 
bath. Both pre- and postsynaptic neurons were impaled with 
two glass micropipettes (3 M KCI) for current- or voltage-clamp 
measurements. ACh release was reflected by the amplitude of 
the postsynaptic current response licited by the evoked action 
potential in the presynaptic neuron. The action potential was 
not affected by any toxin, chains or fragments. Intracellular ap- 
plication of toxin, chain or the fragment B was achieved by an 
air pressure injection through a third micropipette [6-8,12]. 
3. RESULTS 
Extracellular application of the two-chain form 
of tetanus toxin to the cholinergic synapse in the 
buccal ganglion of Aplysia induced a time- 
dependent and irreversible depression of transmis- 
sion (fig.l). At 10 -6 M, 5007o decrease in the 
amplitude of evoked postsynaptic responses was 
observed within 3 h. The two-chain forms of TeTx 
(BE and BC) were equip•tent. By comparison to 
the action of BoNT A, TeTx is more than 100-fold 
less potent (fig. 1). Bath addition of TeTx (10 -6 M) 
to the BoNT-resistant [6] non-cholinergic synapses 
in the cerebral ganglia [13,14] induced a rapid 
decrease in transmission (50070 blockade after 
25 min, not shown). This suggests that the lower 
potency of TeTx applied extraceIlularly to depress 
the cholinergic terminal is due to a weak inter- 
nalization of the toxin. Accordingly, when this 
step was by-passed by an intracellular injection of 
TeTx, a time-dependent i hibition of ACh release 
was induced even by a low concentration of TeTx 
(fig.2A): note that a complete blockade was 
observed within 2 h for an estimated intracellular 
concentration i the 10 -? M range. 
Intracellularly injected LC alone depressed ACh 
release with a potency equivalent o that of in- 
tracellularly applied TeTx (fig.2). Injected frag- 
ment B was as effective as LC. In contrast, injected 
HC alone was not toxic. When added to the bath 
alone, neither LC nor HC affected ACh release 
(fig.3). However, an irreversible decrease of ACh 
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Fig.3. Depression of ACh release by extracellular pplication of 
TeTx. The presence of both HC and LC is required. Bath 
application (first hatched areas) of isolated chains of TeTx 
(10 -6 M HC, upper graph or 10 -6 M LC, lower graph) did not 
modify synaptic transmission. Upon addition (second hatched 
area) of the other chain (LC or HC, 10 -6 M each, respectively) 
blockade of transmission ensued to an extent similar to that 
observed with TeTx (see fig.l). 
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release was observed when both chains were pre- 
sent together in the bath (fig.3). The extent of this 
decrease was similar to that induced by the same 
concentration of the two-chain TeTx (cf. with 
fig.l). Thus it appears that LC contains site(s) 
leading to the depression of transmitter elease 
when inside the neuron, whereas its uptake from 
outside requires the presence of HC. 
Since the amino-terminal moiety of the HC is in- 
volved in the internalization of BoNT in Aplysia 
[8], we tested this possibility for TeTx too. Ex- 
tracellularly applied fragment B (10 -6 M) of TeTx 
induced a similar depression of ACh release to that 
induced by the same concentration of TeTx BE or 
BC (not shown). When its constituent, polypep- 
tides/?2 (that was not toxic alone) and LC were ap- 
plied simultaneously in the bath (each at 10 -6 M) 
a similar decrease to that induced by B fragment or 
TeTx ensued. This indicates that the amino- 
terminal moiety of the HC is involved in the inter- 
nalization of TeTx into Aplysia neurons. 
4. DISCUSSION 
TeTx inhibits neurotransmitter release not only 
at non-cholinergic but also, with less efficacy, at 
cholinergic neuronal synapses in Aplysia. Our 
results are in good agreement with previous reports 
that TeTx ~ blocks the release of various 
neurotransmitters like glycine and GABA [15], and 
noradrenaline [16] in rat brain and was less potent 
than BoNT in motor end-plate terminals [17,18]. 
Compared to BoNT A or B [6,7], TeTx appears 
less potent (more than 100-fold) on cholinergic 
cells of Aplysia, this is similar to the effect on 
vertebrate motor end-plates [17,18]. However 
when injected into the cholinergic neuron TeTx ex- 
hibited a potency as strong as that of intracellular- 
ly applied BoNT type A or B [6,7]. This indicates 
that the observed difference in efficacy of TeTx 
and BoNT results rather from dissimilarities in ex- 
tracellular targetting the toxins to the terminal 
membrane than from quantitatively different in- 
tracellular actions. 
Once within the neuron TeTx LC alone is toxic. 
Although BoNT and TeTx have a similar two- 
chain form structure [1,2], this result contrasts 
with the intracellular requirement of both LC and 
HC of BoNT A or B in ch01inergic neurons of 
Aplysia [6,7]. Actually, the HzL fragment of 
BoNT A, homologous to fragment B of TeTx, is 
not toxic intracellularly [8] whereas fragment B is. 
LC can mimick the action of TeTx when applied 
into the cell but not to its surface, thus the chain 
cannot enter the neuron on its own. The inter- 
nalization process needs the presence of the HC. 
The carrier function of HC of clostridial toxins 
(TeTx or BoNT) is supported by their role in bin- 
ding of TeTx or BoNT to membrane acceptors 
[10,19-21]. Native and reconstituted TeTx BE, or 
HC but not LC bind to rat brain membranes 
[10,19]. Fragment B does not affect ACh release at 
the vertebrate motor end-plate [22], perhaps 
because here the carboxy-terminus of HC (called C 
fragment) of TeTx is required for binding to mem- 
brane gangliosides (see for review [1,2]). However, 
an additional contribution of the amino-terminus 
of HC was also reported for TeTx binding to rat 
brain membranes [10]. In Aplysia, as evident from 
the depression of ACh release induced by fragment 
B or a mixture offl2 and LC, the region of HC in- 
volved in the internalization step is the amino- 
terminal f12. The same role was attributed to the 
amino-terminal HE of BoNT homologous to ~2 of 
TeTx [8], 
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